195 related articles for article (PubMed ID: 1310779)
21. A point mutation within conserved region VI of herpes simplex virus type 1 DNA polymerase confers altered drug sensitivity and enhances replication fidelity.
Hwang YT; Zuccola HJ; Lu Q; Hwang CB
J Virol; 2004 Jan; 78(2):650-7. PubMed ID: 14694096
[TBL] [Abstract][Full Text] [Related]
22. Identification of a gene function of herpes simplex virus type 1 essential for amplification of simian virus 40 DNA sequences in transformed hamster cells.
Matz B; Schlehofer JR; zur Hausen H
Virology; 1984 Apr; 134(2):328-37. PubMed ID: 6100573
[TBL] [Abstract][Full Text] [Related]
23. Effects of mutations in the Exo III motif of the herpes simplex virus DNA polymerase gene on enzyme activities, viral replication, and replication fidelity.
Hwang YT; Liu BY; Coen DM; Hwang CB
J Virol; 1997 Oct; 71(10):7791-8. PubMed ID: 9311864
[TBL] [Abstract][Full Text] [Related]
24. Engineered herpes simplex virus DNA polymerase point mutants: the most highly conserved region shared among alpha-like DNA polymerases is involved in substrate recognition.
Marcy AI; Hwang CB; Ruffner KL; Coen DM
J Virol; 1990 Dec; 64(12):5883-90. PubMed ID: 2173770
[TBL] [Abstract][Full Text] [Related]
25. Novel mutations in the thymidine kinase and DNA polymerase genes of acyclovir and foscarnet resistant herpes simplex viruses infecting an immunocompromised patient.
Chibo D; Mijch A; Doherty R; Birch C
J Clin Virol; 2002 Aug; 25(2):165-70. PubMed ID: 12367650
[TBL] [Abstract][Full Text] [Related]
26. Site-specific mutagenesis of a highly conserved region of the herpes simplex virus type 1 DNA polymerase gene.
Dorsky DI; Crumpacker CS
J Virol; 1990 Mar; 64(3):1394-7. PubMed ID: 2154619
[TBL] [Abstract][Full Text] [Related]
27. [Resistance of herpes simplex viruses to antiviral drugs].
Scieux C; Bianchi A
Pathol Biol (Paris); 1993 Feb; 41(2):172-7. PubMed ID: 8392160
[TBL] [Abstract][Full Text] [Related]
28. [Genotyping diagnosis of acyclovir resistant herpes simplex virus].
Frobert E; Thouvenot D; Lina B; Morfin F
Pathol Biol (Paris); 2007 Dec; 55(10):504-11. PubMed ID: 17920786
[TBL] [Abstract][Full Text] [Related]
29. Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity?
Sacks SL; Wanklin RJ; Reece DE; Hicks KA; Tyler KL; Coen DM
Ann Intern Med; 1989 Dec; 111(11):893-9. PubMed ID: 2554768
[TBL] [Abstract][Full Text] [Related]
30. Mutation within the herpes simplex virus DNA polymerase gene conferring resistance to (R)-9-(3,4-dihydroxybutyl)guanine.
Chiou HC; Kerns KM; Coen DM
Antimicrob Agents Chemother; 1986 Sep; 30(3):502-4. PubMed ID: 3022642
[TBL] [Abstract][Full Text] [Related]
31. Resistance of herpes simplex virus to acycloguanosine--genetic and physical analysis.
Crumpacker CS; Chartrand P; Subak-Sharpe JH; Wilkie NM
Virology; 1980 Aug; 105(1):171-84. PubMed ID: 6251603
[No Abstract] [Full Text] [Related]
32. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome.
Chatis PA; Miller CH; Schrager LE; Crumpacker CS
N Engl J Med; 1989 Feb; 320(5):297-300. PubMed ID: 2536137
[No Abstract] [Full Text] [Related]
33. General aspects of virus drug resistance with special reference to herpes simplex virus.
Coen DM
J Antimicrob Chemother; 1986 Oct; 18 Suppl B():1-10. PubMed ID: 3025148
[TBL] [Abstract][Full Text] [Related]
34. Resistance of herpes simplex virus to acycloguanosine: role of viral thymidine kinase and DNA polymerase loci.
Schnipper LE; Crumpacker CS
Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2270-3. PubMed ID: 6246532
[TBL] [Abstract][Full Text] [Related]
35. Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome.
Birch CJ; Tachedjian G; Doherty RR; Hayes K; Gust ID
J Infect Dis; 1990 Sep; 162(3):731-4. PubMed ID: 2167340
[TBL] [Abstract][Full Text] [Related]
36. Resistance of herpes simplex virus to 9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]guanine: physical mapping of drug synergism within the viral DNA polymerase locus.
Crumpacker CS; Kowalsky PN; Oliver SA; Schnipper LE; Field AK
Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1556-60. PubMed ID: 6324203
[TBL] [Abstract][Full Text] [Related]
37. Herpes simplex type 1 defective interfering particles do not affect the antiviral activity of acyclovir, foscarnet and adenine arabinoside.
Harmenberg JG; Svensson LT
Acta Virol; 1988 Mar; 32(2):153-5. PubMed ID: 2899962
[TBL] [Abstract][Full Text] [Related]
38. Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.
Piret J; Goyette N; Eckenroth BE; Drouot E; Götte M; Boivin G
J Virol; 2015 Apr; 89(8):4636-44. PubMed ID: 25673718
[TBL] [Abstract][Full Text] [Related]
39. Acyclovir-resistant herpes simplex virus causing pneumonia after marrow transplantation.
Ljungman P; Ellis MN; Hackman RC; Shepp DH; Meyers JD
J Infect Dis; 1990 Jul; 162(1):244-8. PubMed ID: 2162368
[TBL] [Abstract][Full Text] [Related]
40. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.
Safrin S; Crumpacker C; Chatis P; Davis R; Hafner R; Rush J; Kessler HA; Landry B; Mills J
N Engl J Med; 1991 Aug; 325(8):551-5. PubMed ID: 1649971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
